The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/10216/152487 |
Resumo: | Liquid biopsy is an emerging technology with a potential role in the screening and early detection of lung cancer. Several liquid biopsy-derived biomarkers have been identified and are currently under ongoing investigation. In this article, we review the available data on the use of circulating biomarkers for the early detection of lung cancer, focusing on the circulating tumor cells, circulating cell-free DNA, circulating micro-RNAs, tumor-derived exosomes, and tumor-educated platelets, providing an overview of future potential applicability in the clinical practice. While several biomarkers have shown exciting results, diagnostic performance and clinical applicability is still limited. The combination of different biomarkers, as well as their combination with other diagnostic tools show great promise, although further research is still required to define and validate the role of liquid biopsies in clinical practice. |
id |
RCAP_8e8778b608a5b550f986795ba3c5e498 |
---|---|
oai_identifier_str |
oai:repositorio-aberto.up.pt:10216/152487 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The Role of Liquid Biopsy in Early Diagnosis of Lung CancerCell-free DNACirculating tumor associated cellsClinical biomarkers detectionExosomesLiquid biopsyLung cancerTumor-educated plateletsLiquid biopsy is an emerging technology with a potential role in the screening and early detection of lung cancer. Several liquid biopsy-derived biomarkers have been identified and are currently under ongoing investigation. In this article, we review the available data on the use of circulating biomarkers for the early detection of lung cancer, focusing on the circulating tumor cells, circulating cell-free DNA, circulating micro-RNAs, tumor-derived exosomes, and tumor-educated platelets, providing an overview of future potential applicability in the clinical practice. While several biomarkers have shown exciting results, diagnostic performance and clinical applicability is still limited. The combination of different biomarkers, as well as their combination with other diagnostic tools show great promise, although further research is still required to define and validate the role of liquid biopsies in clinical practice.Frontiers Media20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/152487eng2234-943X10.3389/fonc.2021.634316Freitas, CSousa, CMachado, FSerino, MSantos, VMartins, NTeixeira, ACunha, APereira, TOliveira, HPCosta, JLHespanhol, Vinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T15:33:08Zoai:repositorio-aberto.up.pt:10216/152487Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:26:24.933222Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer |
title |
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer |
spellingShingle |
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer Freitas, C Cell-free DNA Circulating tumor associated cells Clinical biomarkers detection Exosomes Liquid biopsy Lung cancer Tumor-educated platelets |
title_short |
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer |
title_full |
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer |
title_fullStr |
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer |
title_full_unstemmed |
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer |
title_sort |
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer |
author |
Freitas, C |
author_facet |
Freitas, C Sousa, C Machado, F Serino, M Santos, V Martins, N Teixeira, A Cunha, A Pereira, T Oliveira, HP Costa, JL Hespanhol, V |
author_role |
author |
author2 |
Sousa, C Machado, F Serino, M Santos, V Martins, N Teixeira, A Cunha, A Pereira, T Oliveira, HP Costa, JL Hespanhol, V |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Freitas, C Sousa, C Machado, F Serino, M Santos, V Martins, N Teixeira, A Cunha, A Pereira, T Oliveira, HP Costa, JL Hespanhol, V |
dc.subject.por.fl_str_mv |
Cell-free DNA Circulating tumor associated cells Clinical biomarkers detection Exosomes Liquid biopsy Lung cancer Tumor-educated platelets |
topic |
Cell-free DNA Circulating tumor associated cells Clinical biomarkers detection Exosomes Liquid biopsy Lung cancer Tumor-educated platelets |
description |
Liquid biopsy is an emerging technology with a potential role in the screening and early detection of lung cancer. Several liquid biopsy-derived biomarkers have been identified and are currently under ongoing investigation. In this article, we review the available data on the use of circulating biomarkers for the early detection of lung cancer, focusing on the circulating tumor cells, circulating cell-free DNA, circulating micro-RNAs, tumor-derived exosomes, and tumor-educated platelets, providing an overview of future potential applicability in the clinical practice. While several biomarkers have shown exciting results, diagnostic performance and clinical applicability is still limited. The combination of different biomarkers, as well as their combination with other diagnostic tools show great promise, although further research is still required to define and validate the role of liquid biopsies in clinical practice. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021 2021-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/10216/152487 |
url |
https://hdl.handle.net/10216/152487 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2234-943X 10.3389/fonc.2021.634316 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Frontiers Media |
publisher.none.fl_str_mv |
Frontiers Media |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799136177302798336 |